Earnings season brings clarity—and volatility. Several companies have recently released earnings reports and financial outlooks, providing a glimpse into the performance of various sectors. Today we'll focus on Halozyme (HALO) and CGI Group (GIB).
Halozyme (HALO) is making headlines after raising its 2026 financial guidance. The company now anticipates total revenue between $1,710 and $1,810 million, reflecting year-over-year growth of 23% to 30%. Royalty revenue is projected to land between $1,130 and $1,170 million, a 30% to 35% increase. This positive outlook is further supported by the acquisition of Surf Bio, a biopharmaceutical company, in December 2025, signaling a strategic expansion in drug delivery technology. HALO shares are currently up +0.50%.
CGI Group (GIB), trading on the NYSE, reported its first quarter Fiscal 2026 results, showcasing a 7.7% year-over-year revenue increase, reaching $4.08 billion. The company's cash from operating activities totaled $871.9 million, representing 21.4% of revenue. Bookings reached $4.47 billion, resulting in a book-to-bill ratio of 109.5%. GIB shares are down -1.08% today. Textron (TXT) also reported Q4 2025 results, with adjusted income from continuing operations at $1.73 per share, compared to $1.34 per share in the fourth quarter of 2024. TXT shares are down -0.43%.
Taboola (TBLA) announced it will release its fourth quarter and full year 2025 financial results on February 25, 2026. Investors will be watching closely to see how the advertising technology company performed, especially given the changing landscape of digital advertising. TBLA shares are down -0.48% today, but this is likely due to broader market conditions rather than direct reaction to the earnings announcement.
Expectations are set. Now comes execution.